Comparison of levofloxacin-based triple therapy and levofloxacin plus Tetracycline-based quadruple therapy

被引：0
|
作者：
Tseng, Kuo-Lun [1 ]
Wu, Tzung-Shiun [1 ]
Chang, Lin-Li [2 ]
Wu, Jeng-Yih [3 ]
Wu, Deng-Chyang [4 ]
Wang, Wen-Ming [3 ]
机构：
[1] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Dept Microbiol, Kaohsiung, Taiwan
[3] Kaohsiung Municipal Tatung Hosp, Div Internal Med, Kaohsiung, Taiwan
[4] Kaohsiung Municipal Hsiaokang Hosp, Div Internal Med, Kaohsiung, Taiwan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1640
引用
收藏
页码：126 / 127
页数：2
相关论文
共 50 条
  • [1] Comparison of 10-day levofloxacin bismuth-based quadruple therapy and levofloxacin-based triple therapy for Helicobacter pylori
    Wu, Tzung-Shiun
    Hsu, Ping-I
    Kuo, Chao-Hung
    Hu, Huang-Ming
    Wu, I-Chen
    Wang, Sophie S. W.
    Chen, Yen-Hsu
    Wu, Deng-Chyang
    Su, Wei-Wen
    Kuo, Fu-Chen
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2017, 18 (09) : 537 - 542
  • [2] Efficacy of levofloxacin-based triple therapy as a second-line therapy after triple therapy failure
    Mahachai, Varocha
    Chaithongrat, Supakarn Chaithongrat
    Vilaichone, Ratha-Korn
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 103 - 103
  • [3] Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy:: A multicentre study
    Zullo, A.
    De Francesco, V.
    Scaccianoce, G.
    Manes, G.
    Efrati, C.
    Hassan, C.
    Maconi, G.
    Pighonica, D.
    Cannaviello, C.
    Panella, C.
    Morini, S.
    Lerardi, E.
    [J]. DIGESTIVE AND LIVER DISEASE, 2007, 39 (09) : 806 - 810
  • [4] EFFICACY OF LEVOFLOXACIN-BASED TRIPLE THERAPY AS A SECOND-LINE THERAPY AFTER TRIPLE THERAPY FAILURE
    Mahachai, V.
    Thongbai, T.
    Vilaichone, R.
    [J]. HELICOBACTER, 2012, 17 : 101 - 101
  • [5] A RANDOMIZED CONTROLLED STUDY FOR LEVOFLOXACIN-BASED QUADRUPLE THERAPY IN HELICOBACTER PYLORI ERADICATION
    Yingyongthawat, Worapoth
    Pulsombat, Akharawit
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S535 - S535
  • [6] Efficacy of rabeprazole/levofloxacin-based triple therapy for Helicobacter pylori eradication
    Cammarota, G
    Cianci, R
    Vero, V
    Urgesi, R
    Gasbarrini, G
    [J]. GUT, 2002, 51 : A95 - A95
  • [7] Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection:: A meta-analysis
    Saad, RJ
    Schoenfeld, P
    Kim, HM
    Chey, WD
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (03): : 488 - 496
  • [8] Second-line rescue anti-Helicobacter pylori therapy without Bismuth salts: a prospective randomized controlled study comparing levofloxacin-based and tetracycline-based triple therapy
    Chuah, Seng-Kee
    Tai, Wei-Chen
    Hu, Tsung-Hui
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A160 - A160
  • [9] Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment:: a randomized trial
    Nista, EC
    Candelli, M
    Cremonini, F
    Cazzato, IA
    Di Caro, S
    Gabrielli, M
    Santarelli, L
    Zocco, MA
    Ojetti, V
    Carloni, E
    Cammarota, G
    Gasbarrini, G
    Gasbarrini, A
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (06) : 627 - 633
  • [10] Clinical trial:: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection
    Yee, Y. K.
    Cheung, T. K.
    Chu, K.-M.
    Chan, C. K.
    Fung, J.
    Chan, P.
    But, D.
    Hung, I.
    Chan, A. O. O.
    Yuen, M. F.
    Hsu, A.
    Wong, B. C. Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (07) : 1063 - 1067
12345